enoxaparin, Lovenox

  • Pharmacy Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: Jay W. Marks, MD
    Jay W. Marks, MD

    Jay W. Marks, MD

    Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.

Deep Vein Thrombosis (DVT)

PRESCRIPTION: Yes

GENERIC AVAILABLE: Yes

PREPARATIONS: Enoxaparin is available in pre-filled syringes containing 30, 40, 60, 80, 100, 120, and 150 mg. Multiple dose vial: 300 mg

STORAGE: All enoxaparin products should be stored at room temperature, between 15 and 30 C (59 and 86 F).

DOSING: Enoxaparin is administered by injection under the skin (subcutaneous) or intravenously.

  • Preventing deep vein thrombosis after abdominal surgery: 40 mg subcutaneous injection once daily.
  • Preventing deep vein thrombosis after knee replacement: 30 mg subcutaneous injection every 12 hours.
  • Preventing deep vein thrombosis after hip replacement: 30 mg every 12 hours or 40 mg once daily by subcutaneous injection.
  • Preventing deep vein thrombosis in ill patients with limited mobility: 40 mg subcutaneous injection once daily.
  • Treatment of deep vein thrombosis or pulmonary embolism: 1 mg/kg every 12 hours or 1.5 mg/kg once daily by subcutaneous injection.
  • Outpatient treatment of deep vein thrombosis: 1 mg/kg subcutaneous injection every 12 hours.
  • Treatment of severe heart attacks (ST elevation myocardial infarction or STEMI): For patients under the age of 75, 30 mg intravenously plus 1 mg/kg subcutaneously followed by 1 mg/kg every 12 hours (maximum of 100 mg for each of the first two subcutaneous doses only). For patients over age 75, 0.75 mg/kg subcutaneously every 12 hours (maximum of 75 mg for each of the first two subcutaneous doses only). All patients should receive aspirin. Doses should be reduced in patients with impaired kidney function.
  • Treatment of chest pain (unstable angina) or mild heart attack (non-Q-wave myocardial infarction): 1 mg/kg subcutaneously every 12 hours with aspirin.
  • For coronary artery stent procedures (percutaneous coronary intervention or PCI): Patients should receive 0.3 mg/kg during stent placement if the last dose of enoxaparin was administered more than 8 hours before the procedure.
Medically Reviewed by a Doctor on 8/5/2015

Quick GuideDeep Vein Thrombosis (DVT): Symptoms, Treatment & Prevention

Deep Vein Thrombosis (DVT): Symptoms, Treatment & Prevention
FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

See more info: enoxaparin on RxList
RxList Logo

Need help identifying pills and medications?

Use the pill identifier tool on RxList.

Subscribe to MedicineNet's Heart Health Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors